Checkmate Pharmaceuticals

Please note: The information displayed on this page might be outdated.
Checkmate Pharmaceuticals: Checkmate Pharmaceuticals is a clinical stage company that is leveraging its expertise in the field of CpG
oligonucleotides to discover and develop immunotherapies designed to increase the efficacy of existing
immunotherapies and to provide new treatment options for patients and their healthcare providers.
Checkmate’s lead product candidate, CMP-001, is an investigational cancer immunotherapeutic that has
been shown to reverse resistance to PD-1 therapy in some patients.
Based in...
US - New England
Clinical Stage
Phase l or ll
Disease Space
Public, USA
Market Cap
100MM - 500MM
101 Main Street
Suite 1400
Cambridge, Massachusetts 02142
United States

Company Participants at Private Company Showcase NYC 2019

  • Barry Labinger, President/CEO

Top 10 Holders of Checkmate Pharmaceuticals, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
venBio Partners LLC 16.99 3,673,374 19.65 13F 3/31/21
Sofinnova Investments, Inc. 16.68 3,606,707 19.30 13F 3/31/21
Novo Holdings A/S 10.04 2,170,100 11.61 13F 3/31/21
Clough Capital Partners LP 7.18 1,552,326 8.30 Stakes 5/7/21
Medicxi Ventures Management (Jersey) Ltd. 6.95 1,501,716 8.03 13F 3/31/21
Omega Fund Management LLC 6.18 1,335,050 7.14 13F 3/31/21
Impresa Management LLC 4.47 966,226 5.17 13F 3/31/21
Sectoral Asset Management, Inc. 2.51 541,766 2.90 13F 3/31/21
DNCA Finance SA 2.34 505,290 2.70 Funds 12/31/20
Vanguard Group, Inc. (Subfiler) 1.67 360,712 1.93 13F 3/31/21
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.